Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by Irena Draskovic
Telomerase Activation and ATRX Mutations Are Independent Risk Factors for Metastatic Pheochromocytoma and Paraganglioma
Clinical Cancer Research
Cancer Research
Oncology
Related publications
Constitutional Telomerase Mutations Are Genetic Risk Factors for Cirrhosis
Hepatology
Medicine
Hepatology
Plasma Methoxytyramine: A Novel Biomarker of Metastatic Pheochromocytoma and Paraganglioma in Relation to Established Risk Factors of Tumour Size, Location and SDHB Mutation Status
European Journal of Cancer
Cancer Research
Oncology
Efficacy and Safety of Ablative Therapy in the Treatment of Patients With Metastatic Pheochromocytoma and Paraganglioma
Cancers
Cancer Research
Oncology
Two Independent Regions of Human Telomerase Reverse Transcriptase Are Important for Its Oligomerization and Telomerase Activity
Journal of Biological Chemistry
Biochemistry
Cell Biology
Molecular Biology
Temozolomide Is a Potential Therapeutic Tool for Patients With Metastatic Pheochromocytoma/Paraganglioma—Case Report and Review of the Literature
Frontiers in Endocrinology
Endocrinology
Metabolism
Diabetes
FGF21 Levels in Pheochromocytoma/Functional Paraganglioma
Cancers
Cancer Research
Oncology
Metabolic Implications of Hypoxia and Pseudohypoxia in Pheochromocytoma and Paraganglioma
Cell and Tissue Research
Forensic Medicine
Pathology
Histology
Cell Biology
Plasma Methoxytyramine: Clinical Utility With Metanephrines for Diagnosis of Pheochromocytoma and Paraganglioma
European Journal of Endocrinology
Medicine
Endocrinology
Metabolism
Diabetes
Therapies Targeting the Signal Pathways of Pheochromocytoma and Paraganglioma
OncoTargets and Therapy
Oncology
Pharmacology